Non Small Cell Lung Cancer News and Research

RSS

Non-Small Cell Lung Cancers are a group of lung cancers that are named for the kinds of cells found in the cancer and how the cells look under a microscope. The three main types of non-small cell lung cancer are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma. Non-small cell lung cancer is the most common kind of lung cancer.

Woman’s velvety tripe palms turn out to be a sign of lung cancer

A 73-year-old woman presented with pruritic, itchy, and painful lesions on her hand, showing an appearance consisted of tripe palms. It was later revealed by doctors that her velvety palms turned out to be a rare sign of lung cancer.

19 Nov 2019

Improving the efficiency of antiangiogenic and antifibrotic drug for treatment of lung cancer

The University of Barcelona and Hospital Clínic de Barcelona collaborate with Boehringer Ingelheim Inc. to improve the efficiency of nintedanib, an antiangiogenic and antifibrotic drug, for the treatment of lung cancer.

19 Nov 2019

Patients treated at NCI-designated centers more likely to receive high-cost lung cancer drugs

Genetically targeted drugs and immunotherapies are transforming the way we treat many forms of lung cancer.

19 Nov 2019

Rutgers Cancer Institute researchers awarded $2.3 million in American Cancer Society grants

More than $2.3 million in Research Scholar Grants from the American Cancer Society have been awarded to three Rutgers Cancer Institute of New Jersey researchers to examine cell metabolism and tumor formation in forms of breast cancer, lung cancer and leukemia.

19 Nov 2019

Surgery can improve survival rate for oldest patients with early stage lung cancer

Many patients with early stage lung cancer who are age 90 years and older do not receive treatment; however, surgery in this nonagenarian population should be considered because it could significantly increase the chances for 5-year survival, according to research published online today in The Annals of Thoracic Surgery.

19 Nov 2019

Cancer patients with RA treated with immune checkpoint inhibitors likely to experience a flare

A new study found that cancer patients with a pre-existing autoimmune disease receiving immune checkpoint inhibitors as treatment are likely to experience a flare.

11 Nov 2019

Study: Pleural effusions are linked with NSCLC and malignant mesothelioma

Cryopreserved cell-free PE fluid from 101 NSCLC patients, 8 mesothelioma and 13 with benign PE was assayed for a panel of 40 cytokines/chemokines using the Luminex system.

6 Nov 2019

HIMC at Mount Sinai to evaluate therapeutic effects of novel cancer immunotherapy

The Human Immune Monitoring Center at the Icahn School of Medicine at Mount Sinai will apply cutting-edge high-throughput technologies to evaluate the therapeutic effects of Libtayo (cemiplimab-rwlc), a PD-1 antibody blockade developed by biotechnology company Regeneron Pharmaceuticals, Inc and Sanofi.

5 Nov 2019

Research finds disparities in receiving recommended treatment for lung cancer

Only about 6 in 10 lung cancer patients in the United States receive the minimal lung cancer treatments recommended by the National Comprehensive Cancer Network guidelines, according to new research published online in the Annals of the American Thoracic Society.

30 Oct 2019

Disrupting key immune regulator boosts anti-tumor immunity, enables cancer clearance

The immune system must strike an exquisite balance between vanquishing infections and cancer, while at the same time restraining its activity to avoid inadvertently attacking the body's healthy tissues and organs.

23 Oct 2019

Dartmouth scientist awarded grant to build new AI technologies for lung cancer management

Lung cancer is the second most common type of cancer and leading cause of cancer death in men and women, with non-small cell lung cancer (NSCLC) accounting for up to 90% of cases. Somatic mutations heavily impact the sensitivity of NSCLC patients to various drug treatments, and are critical for choosing the most effective targeted therapies for this cancer.

23 Oct 2019

CRISPR helps find difficult to detect cancer cells

Immunotherapy is one of the latest and most effective armaments against various types of cancers. Some of the immunotherapy drugs such as PD-1 inhibitor Keytruda from Merck can block certain proteins in the cancer cells that can make the cells invisible to the immune system normally. Some of the cancers cells can now develop other ways to disguise themselves from being killed by the immune system.

15 Oct 2019

Non Small Cell Lung Cancer News and Research

Woman’s velvety tripe palms turn out to be a sign of lung cancer

Improving the efficiency of antiangiogenic and antifibrotic drug for treatment of lung cancer

Patients treated at NCI-designated centers more likely to receive high-cost lung cancer drugs

Rutgers Cancer Institute researchers awarded $2.3 million in American Cancer Society grants

Surgery can improve survival rate for oldest patients with early stage lung cancer

Cancer patients with RA treated with immune checkpoint inhibitors likely to experience a flare

Study: Pleural effusions are linked with NSCLC and malignant mesothelioma

HIMC at Mount Sinai to evaluate therapeutic effects of novel cancer immunotherapy

Research finds disparities in receiving recommended treatment for lung cancer

Disrupting key immune regulator boosts anti-tumor immunity, enables cancer clearance

Dartmouth scientist awarded grant to build new AI technologies for lung cancer management

CRISPR helps find difficult to detect cancer cells

Combination of two drugs disrupts cancer cells' ability to survive DNA damage, study finds

New algorithm hand-picks which cancer mutations are promising targets for immunotherapy

Lung cancer may soon be picked up by a blood test

Higher levels of genetic mutations linked to improved outcomes in lung cancer patients

Combination therapy may offer new therapeutic avenue for previously-treated NSCLC and kidney cancer patients

Adding radiation after immunotherapy increases PFS for some patients with metastatic NSCLC

Investigational drug may offer new treatment option for patients with lung and kidney cancer

Reactivating ‘tumor suppressor’ genes could offer new therapeutic approach for cancer

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News